Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
www.marketwatch.com
#Pfizer #sticks #profit #view #shrugs #plunging #Paxlovid #sales #COVID
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID
